Updated developments on molecular imaging and therapeutic strategies directed against necrosis.
10.1016/j.apsb.2019.02.002
- Author:
Dongjian ZHANG
1
;
Meng GAO
1
;
Qiaomei JIN
1
;
Yicheng NI
1
;
Jian ZHANG
1
Author Information
1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.
- Publication Type:Journal Article
- Keywords:
Exposed DNA;
Molecular imaging;
Myocardial infarction;
Necrosis avid agents;
Solid tumor;
Targeted therapy
- From:
Acta Pharmaceutica Sinica B
2019;9(3):455-468
- CountryChina
- Language:English
-
Abstract:
Cell death plays important roles in living organisms and is a hallmark of numerous disorders such as cardiovascular diseases, sepsis and acute pancreatitis. Moreover, cell death also plays a pivotal role in the treatment of certain diseases, for example, cancer. Noninvasive visualization of cell death contributes to gained insight into diseases, development of individualized treatment plans, evaluation of treatment responses, and prediction of patient prognosis. On the other hand, cell death can also be targeted for the treatment of diseases. Although there are many ways for a cell to die, only apoptosis and necrosis have been extensively studied in terms of cell death related theranostics. This review mainly focuses on molecular imaging and therapeutic strategies directed against necrosis. Necrosis shares common morphological characteristics including the rupture of cell membrane integrity and release of cellular contents, which provide potential biomarkers for visualization of necrosis and necrosis targeted therapy. In the present review, we summarize the updated joint efforts to develop molecular imaging probes and therapeutic strategies targeting the biomarkers exposed by necrotic cells. Moreover, we also discuss the challenges in developing necrosis imaging probes and propose several biomarkers of necrosis that deserve to be explored in future imaging and therapy research.
